Results 81 to 90 of about 301,386 (199)

Inflammatory Breast Cancer and Transient Complete Radiographic Response to Chemoimmunotherapy: A Case Report

Case Reports in Oncology
Introduction: Inflammatory breast cancer is a rare and aggressive subtype, with high breast cancer mortality. Compared to noninflammatory breast cancer, even after treatment and response to standard-of-care breast cancer chemotherapy, it has a high ...
Adina Amin, Sasis Sirikanjanapong, Amardeep Kalsi, Evelyn Taiwo   +3 more
doaj   +1 more source

Congestive Heart Failure versus Inflammatory Carcinoma in Breast

Case Reports in Radiology, 2014
Inflammatory breast cancer is a rare highly malignant form of breast cancer. Clinical signs and symptoms with histologic examination usually confirm the diagnosis. There are rare reports of breast edema of congestive heart failure which were difficult to
A. Alikhassi, R. Omranipour, Z. Alikhassy   +2 more
doaj   +1 more source

Polycomb proteins and breast cancer

, 2013
In the Western world, breast cancer is the most frequent malignancy in women and still the leading cause of cancer related deaths, therefore, a better understanding of the disease is needed.
Fedele, Vita
core  

The role of receptor tyrosine kinase signalling in HER-2-positive cells and trastuzumab (Herceptin) resistance in breast cancer [PDF]

, 2009
HER-2 gene amplification or overexpression occurs in approximately 25 % of breast cancers, and trastuzumab (Tmab) is a monoclonal antibody currently used to treat patients with HER-2-overexpressing breast cancer.
Browne, Brigid
core  

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures

, 2011
Background: Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers.
Pusztai, Lajos, Lajos Pusztai, Schmidt Marcus, Karn, Thomas, Lars Hanker, Holtrich Uwe, Ruckhäberle Eugen, Volkmar Müller, Liedtke, Cornelia, Karn Thomas, Shiang Christine Y., Rody Achim, Gätje, Regine, Solbach Christine, Eugen Ruckhäberle, Pusztai Lajos, Müller, Volkmar, Cornelia Liedtke, Rody, Achim, Ahr Andre, Ruckhäberle, Eugen, Marcus Schmidt, Christine Y Shiang, Solbach, Christine, Gaetje Regine, Ahr, André, Andre Ahr, Thomas Karn, Hanker Lars, Achim Rody, Schmidt, Marcus, Shiang, Christine Y., Hanker, Lars, Takayuki Iwamoto, Holtrich, Uwe, Iwamoto Takayuki, Manfred Kaufmann, Liedtke Cornelia, Uwe Holtrich, Christine Solbach, Müller Volkmar, Iwamoto, Takayuki, Kaufmann Manfred, Kaufmann, Manfred, Regine Gaetje   +44 more
core   +1 more source

A Regulatory “miRcircuitry” Involving miR221&222 and ERα Determines ERα Status of Breast Cancer Cells

, 2009
Estrogen Receptor α (ERα) is the most important diagnostic and prognostic factor in breast cancer. Several lines of evidence have suggested that ERα-negative breast tumors, highly aggressive and non-responsive to hormonal therapy, arise from ERα ...
Di Leva, Gianpiero
core  

Surgical Management of Inflammatory Breast Cancer

, 2019
Inflammatory breast cancer (IBC) is a rare clinicopathological entity but remains one of the most aggressive types of breast cancer. The acute edematous infiltration of the skin and breast is met with occasionally, and it is without doubt the most acute ...
Grahovac T., Unal B., Soran A.
core   +1 more source

Molecular and cellular expression of novel genes associated with breast cancer

, 2009
An improved and individualised breast cancer care can be pursued with the use of tumour markers that are associated with risk assessment, diagnosis, prognosis, prediction of treatment outcome, monitoring of the disease and development of novel therapies.
Laversin, S
core  

Inflammatory breast cancer: Results of antracycline-based neoadjuvant chemotherapy

, 2003
Twenty-three patients with inflammatory breast cancer treated with a combined modality approach including anthracycline-based induction chemotherapy-surgery-chemotherapy-radiotherapy were reviewed.
AYDINER, Adnan, Bozfakioglu, Yavuz, Ozmen, Vahit, Topuz, Erkan, Dagoglu, Temel, Dinçer, Maktav, Igci, Abdullah, Bilir, Ayhan, Kecer, Mustafa, Cabioglu, Neslihan   +9 more
core   +1 more source

Molecular gene expression and genome wide profiling in tamoxifen-resistant breast cancer.

, 2010
PhDOestrogen receptor positive (ER+) breast cancers (BC) are heterogeneous in both their clinical behaviour and response to therapy. The ER and Progesterone (PgR) are currently the best predictors of response to the anti-oestrogen tamoxifen, yet up to 40%
Yeoh, Chit Cheng
core